BILLERICA, Mass., Feb. 9, 2018 /PRNewswire/ — Bruker Corporation (NASDAQ: BRKR) announced today it will present at the LEERINK Partners 7th Annual Global Healthcare Conference. Frank Laukien, President and CEO, will participate in a “fireside chat” Q&A session on behalf of the company on Wednesday, February 14th, 2018 at 9:30 AM Eastern Time. A live audio... Read more
FRANKLIN LAKES, N.J., Feb. 8, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018, at 10:00 a.m. ET. A live webcast of BD’s presentation can be accessed from the BD... Read more
Order Contact Careers Account Log In/Register Why CDI Partners & Providers Our Technology Cellular Therapy Drug Discovery Health & Nutrition Stem Cell Banking Products & Services iCell Products iCell Astrocytes iCell Cardiac Progenitor Cells iCell Cardiomyocytes iCell Cardiomyocytes2 iCell DopaNeurons iCell Endothelial Cells iCell GABANeurons iCell GlutaNeurons iCell Hematopoietic Progenitor Cells iCell Hepatoblasts iCell Hepatocytes... Read more
February 8, 2018 Ocean Optics has expanded its spectroscopy capabilities by partnering with Pyreos Limited (Edinburgh, Scotland) to develop new mid-IR solutions. Unlike traditional FT-IR spectrometers, the unique combination of Pyreos’ detectors and Ocean Optics applied spectroscopy knowledge will enable businesses and researchers to create rapid, accurate and field-portable devices. MIR technology makes possible a wealth of... Read more
Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more
Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more
Basel, 08 February 2018 Roche purchases shares in tender offer for Ignyta, Inc. Roche (SIX: RO, ROG; OTCQX: RHHBY) and Ignyta, Inc. today announced that Roche’s wholly owned subsidiary Abingdon Acquisition Corp., has accepted for payment all shares validly tendered and not validly withdrawn pursuant to its tender offer for all outstanding shares of common... Read more
AUSTIN, Texas, Feb. 6, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that management will present at the LEERINK Partners 7th Annual Global Healthcare Conference to be held February 14-15, 2018, in New York, NY. The investor presentation will begin at 10:30 a.m. Eastern time on Thursday, February 15, 2018. The presentation will be webcast live... Read more
QIAGEN’s QuantiFERON-TB customers to gain access to fully automated workflow solution DiaSorin to add novel content to already broad LIAISON menu, over 7,000 systems installed QIAGEN announces milestone of over 40 million QuantiFERON-TB tests since launch January 8, 2018 – Saluggia, Italy; Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Stock Exchange:... Read more
First CatchPoint®SimpleStep®ELISA kits launching at SLAS 2018, Feb 3-7, San Diego, USA Cambridge, UK, San Jose, CA, USA, February 5, 2018: Abcam, a global innovator in life science reagents and tools, and Molecular Devices, LLC, a leading provider of high-performance bioanalytical measurement solutions for the life science industry, today announced a strategic collaboration to develop... Read more